XML 42 R30.htm IDEA: XBRL DOCUMENT v3.25.1

Segment Information (Tables)

3 Months Ended

Mar. 31, 2025

Segment Reporting [Abstract]

Schedule of Net Sales and Operating Profit by Segment

The Company’s net sales, significant segment expenses and operating profit, by reportable segment were:

			Three Months Ended March 31, 2025
			Net sales						Cost of Sales						Selling, general and administrative expenses						Other (income) expense, net (1)						Operating Profit
Reportable Segments
Oral, Personal and Home Care
North America			$	998					$	377					$	415					$	10					$	196
Latin America			1,143						487						316						(7)						348
Europe			690						258						254						7						172
Asia Pacific			690						261						239						(7)						198
Africa/Eurasia			271						104						106						4						57
Total Oral, Personal and Home Care			3,792																								971
Pet Nutrition			1,118						437						422						1						258
Reconciliation with Total Company Operating Profit
Corporate																											(153)
Total			$	4,911																							$	1,076

Note: Table may not sum due to rounding.

(1)Other (income) expense, net primarily includes amortization of intangible assets and equity income.

			Three Months Ended March 31, 2024
			Net sales						Cost of Sales						Selling, general and administrative expenses						Other (income) expense, net (1)						Operating Profit
Reportable Segments
Oral, Personal and Home Care
North America			$	1,035					$	390					$	419					$	13					$	214
Latin America			1,253						502						345						1						405
Europe			673						267						245						8						153
Asia Pacific			727						284						242						(7)						207
Africa/Eurasia			276						106						99						5						66
Total Oral, Personal and Home Care			3,963																								1,044
Pet Nutrition			1,102						482						413						9						199
Reconciliation with Total Company Operating Profit
Corporate																											(196)
Total			$	5,065																							$	1,047

Note: Table may not sum due to rounding.

(1)Other (income) expense, net primarily includes amortization of intangible assets and equity income.

The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:

			Three Months Ended
			March 31,
			2025						2024
Net sales
Oral Care			44		%				43		%
Personal Care			17		%				18		%
Home Care			16		%				17		%
Pet Nutrition			23		%				22		%
Total Net sales			100		%				100		%

Capital expenditures and depreciation and amortization expense by segment were:

			Three Months Ended
			March 31,
			2025						2024
Capital expenditures
Oral, Personal and Home Care
North America			$	17					$	8
Latin America			28						21
Europe			8						8
Asia Pacific			13						9
Africa/Eurasia			2						1
Total Oral, Personal and Home Care			68						47
Pet Nutrition			21						53
Corporate			35						26
Total Capital expenditures			$	124					$	126

			Three Months Ended
			March 31,
			2025						2024
Depreciation and amortization
Oral, Personal and Home Care
North America			$	30					$	31
Latin America			24						27
Europe			15						16
Asia Pacific			20						20
Africa/Eurasia			2						2
Total Oral, Personal and Home Care			92						96
Pet Nutrition			31						30
Corporate			25						24
Total Depreciation and amortization			$	148					$	150

Note: Table may not sum due to rounding.

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration